Endexx's M3Hub(TM) Platform Supports State Legalized Marijuana Laws
M3Hub(TM) and Dispense Labs LLC Targeting Washington State and Colorado Licensees
CAVE CREEK, AZ--(Marketwired - Aug 30, 2013) - Endexx Corporation (OTC Pink: EDXC): Endexx's M3Hub™ recently announced, "Seed to Sale" inventory control, supply chain management, traceability and tracking systems, fully support all State ballot initiatives that have legalized the production, processing, and sale of either Medical Cannabis and/or Recreational Marijuana for distribution in the framework of their Laws. The Department of Justice and the Office of the Deputy Attorney General, announced yesterday "Guidance Regarding Marijuana Enforcement." The DOJ expects these States and local Governments to regulate, enforce and practice procedures that protect the public's safety. M3Hub™ and Autospense™ technology systems provide the infrastructure support needed to administer these accepted responsibilities.
Dispense Labs LLC., a division of Endexx recently announced introduction of its technology solutions in the State of Washington. The system not only supports State Laws but will facilitate compliance of all licensees in Washington that will provide Medical Marijuana, and that grow, process and sell recreational marijuana in the State. Through the M3Hub™ platform, Endexx and Dispense Labs, will collaborate and support State and Local Governments, and Licensees, pursuing a sustainable and law abiding commercial enterprise.
About Endexx:
Endexx Corporation is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software developers, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. Endexx's team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.
The Endexx management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Endexx Corporation is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.
About Dispense Labs
Dispense Labs LLC., has spent several years investing in the research, design and development, and beta testing of Autospense™, a one-of-a-kind technologically driven smart system that allows for the automated dispensing of medical marijuana along with precise inventory control, utilizing predictive analytic algorithm and tracking software.
Autospense™ is a uniquely designed, high-tech automated dispensing system that exceeds industry standards. The software used is specifically designed to properly control transactions and manage inventory. This will significantly improve profitability, accountability, security tracking and customer satisfaction. The Autospense™ solution can easily be integrated with external software and service solutions as well, allowing for other market alliances and business partners to utilize this core technology to support other industry related ancillary services. The Autospense™ system is the only total technology solution in the medical marijuana industry today.
Contact: Todd Davis at Todd.Davis@endexx.com
Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com
http://www.otcmarkets.com/stock/EDXC/quote, www.endexx.com, www.autospense.com
Safe Harbor Statement
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word "believe" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Endexx to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and Endexx assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customer to pay for ordered products, and political and economic risks inherent in international trade.